Great Offshore – BUY Indiainfoline

Indiainfoline Equity Research recommends a BUY in Great Offhsore Ltd with a price Target of Rs 1,029. Key points for the recommendation are as follows,

Great Offshore Ltd (GOL) reported 19.9% yoy growth in net sales to Rs1,523mn in Q2 FY08 as against Rs1,271mn in Q2 FY07. The jump was primarily on account of higher number of vessels operational. Other income jumped from Rs9mn in Q2 FY07 to Rs173mn in Q2 FY08 on account of implementation of AS-11 with effect from April 1, 2007. (more…)

HSBC – SIP with Health Insurance

HSBC – The World’s Local Bank has customized offering of Mutual Fund SIPs in India. This a very innovative scheme and HDFC and Reliance Mutual Funds should also launch such schemes.

Here is the details that we received from HSBC.

  • The insurance will cover cancer, stroke, bypass surgery, accidental death or permanent disability
  • The maximum cover will be for Rs 10 Lakhs.
  • The cover that can be claimed is proportional to SIP amount paid every month. Suppose you invest Rs 2,000 / month, you will get insurance cover of Rs 72,000 over three years as that’s the minimum period you have to stay invested to claim insurance.
  • Eligible age for investor is between 20 and 50 years

Kindly contact HSBC for further details of feedback @ dalalstreet.biz.

Stocks to BUY in Weak Market

Stocks that ShareKhan likes at current level of market (Nifty 5233 # Sensex 17,640) purely from delivery and investment point of view (more volatility is possible over next few days so one should keep 50% – 70% amount aside to buy at lower levels and actually accumulate when these stocks fall ) are :

J P Associates (cmp 1055) our Target is Rs. 1350
Bharti Airtel (cmp 970) our Target is Rs. 1100
SBI (cmp 1665) our Target is Rs. 2282
Shivvani (cmp 365) our Target is Rs. 480
BHEL (cmp 2075) our Target is Rs. 2450
Ranbaxy (cmp 420) our Target is Rs. 500
Aban Lloyds (cmp 3900) our Target is Rs. 4400
Maruti (cmp 1092) we shall put a new Target shortly.

Indo Borax and Chemicals

Indo Borax and Chemicals Ltd. (IBCL), is in the business of manufacturing inorganic chemicals like boric acid, borax and 2 new value-added products – eco borax and glaze bore.

Falling prices of its main raw material – imported boron ore – due to the appreciating Rupee and new mines opening up in East European countries could help IBCL boost its EBIDTA margins. IBCL caters to diversified fast growing user industries like glass, ceramics, pharmaceutical, electroplating, leather, etc, each of which is on a high growth path. IBCL has raised prices of all its products by 15-25% since Oct 01, 2007. This could push its revenues and margins significantly from 2HFY08 onwards. (more…)

Jaiprakash Associates Stock Revaluation

Morgan Stanley has taken the lead to re-rate JP Associates shedding the conservative valuations it enjoyed. They have changed 12 month target price to Rs 1,461 and earnings estimate for FY08 and FY09 are Rs 22.7 and Rs 29.2.

The company reported F2Q08 results in line with estimates, with revenue and net profit growing 11% and 16%, respectively, led mainly by the cement business. Expect construction and real estate to pick up the growth mantle as cement starts to struggle in F2009 . Also incorporated a 7.4% dilution due to the conversion of the second tranche of FCCBs (euro-denominated) issued by Jaiprakash, which results in our EPS numbers for F2008 and F2009 moving up by only 9.1% and 1.8%, respectively, despite increases in net profit forecasts of 12.9% and 9.1%

Sum of Parts Valuation of JP Associates,

  • Construction Business – Rs 395
  • Cement – Rs 435
  • Power – Rs 197
  • Hotels – Rs 13
  • Taj Expressway – Rs 394
  • Jaypee Greens – Rs 28

On the back of value in its sum of the parts, which includes option value for full development of Taj Expressway implies upside of 47% from current levels.

DSP Merill Lynch also said, raised Price Objective to Rs1,530 from Rs985 based on the value creation across businesses.

Buy Allahabad Bank for Long Term

Allahabad Bank’s profit growth of 14% Y-o-Y at INR 2.4 bn in Q2FY08 was ahead of expectations. However, this growth was buoyed by lower tax provisioning (10%) and higher treasury gains (INR 359 mn). Core business performance remained muted with merely 17% Y-o-Y growth in advances and lower-than-expected growth in net interest income at 13% Y-o-Y. The bank’s pre-provisioning operating profit grew by 23% supported by strong treasury gains and a 40.9% growth in the trading income yoy.

The operating expenses grew by a moderate 11.1% yoy which helped the bank in reporting a better operating profit growth of 23.2% yoy. The core operating profit growth was at 19.3% yoy but declined by 13% sequentially. The asset quality remained stable on a sequential basis with the net non-performing asset (NPA) at 0.75% as in September 2007.

At the current market price of Rs95, the stock is quoting at 4.4x its FY2009E EPS, 2.8x PPP and 0.9x BV. One can BUY the stock with a price target of Rs125 and can also hold for long term.

1 7 8 9 10 11 26